モロッコの結核症例における薬剤の副作用と患者のアウトカム
Ouassima Erefai1,2, Sanae Barnou1, Meryem Rais1
1Higher Institute of Nursing Professions and Health Techniques, Rabat, Morocco.
La Tunisie medicale
|February 19, 2026
まとめ
ラバトの結核治療は,患者の31.5%で有害な薬物反応 (ADR) を引き起こし,特に胃腸の問題を引き起こした. 女性および中毒習慣を持つ人は,治療結果に影響を与える,より高いADRリスクに直面しました.
科学分野:
- 公衆衛生は公衆衛生である.
- 感染症 感染症は感染症です.
- 医薬品監視 医薬品監視
背景:
- 結核 (TB) は,長期にわたる抗生物質治療を必要とする重要な世界的な健康問題です.
- この治療法は,様々な副作用 (ADR) と関連しています.
研究 の 目的:
- モロッコのラバトで結核患者の疫学とアウトカムを調査する.
- ADRの発生を評価し,関連する危険因子を特定します.
主な方法:
- 2021年1月から2022年5月までラバトで入院した144人の結核患者 (年齢15歳以上) の遡及的研究.
- 社会人口学的データ,臨床プレゼンテーション,ADR,患者のアウトカムの分析.
- ADR発生に関連する要因を決定するためのロジスティック回帰.
主要な成果:
- 31.5%の患者が少なくとも1つのADRを経験し,胃腸症状が最も一般的であった (50%).
- 女性 (OR=2.123) と中毒習慣を持つ患者 (OR=3.358) は,ADR発生率が著しく高かった.
- 治療の成功率は64.58%で,成功した治療群と失敗した治療群の間でADRの有意な違いはありませんでした.
結論:
- 薬剤の副作用は,結核患者の管理において大きな課題となっています.
- パーソナライズされた治療戦略は,ADRを軽減し,治療の成功率を改善するために不可欠です.
さらに関連する動画
関連する概念動画
01:28Pulmonary Tuberculosis V
660
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
660
01:29Therapeutic Drug Monitoring: Affecting Factors
264
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
264
01:29Pulmonary Tuberculosis I
1.0K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.0K
01:26Pulmonary Tuberculosis IV
559
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
559
01:16Drug toxicity: Idiosyncratic Reactions
41
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
41
01:24Drug Toxicity: Risk factors
33
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
33